IBKS No3 SPAC Cash Flow Conversion Efficiency
IBKS No3 SPAC cash flow conversion efficiency. Based on the latest financial reports, IBKS No3 SPAC (225430) has a cash flow conversion efficiency ratio of -0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-79.11 Million ≈ $-53.61K USD) by net assets (₩26.67 Billion ≈ $18.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of IBKS No3 SPAC (2016–2025)
Cash flow conversion efficiency of IBKS No3 SPAC from 2016 to 2025. This chart illustrates how IBKS No3 SPAC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IBKS No3 SPAC stock price for real-time trading data and today's change.
IBKS No3 SPAC Cash Flow Conversion Ratio Explained
IBKS No3 SPAC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
IBKS No3 SPAC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IBKS No3 SPAC ranked by their cash flow conversion efficiency. Also see IBKS No3 SPAC market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Great Atlantic Resources Corp
V:GR
|
0.014x |
|
Pheton Holdings Ltd Class A Ordinary Shares
NASDAQ:PTHL
|
-0.599x |
|
Evogene
TA:EVGN
|
-0.220x |
|
Sylvania Platinum Limited
LSE:SLP
|
0.095x |
|
Mid Wynd International Investment Trust plc
LSE:MWY
|
0.002x |
|
Constellation Technologies Ltd
AU:CT1
|
0.038x |
|
Sparton Resources Inc
V:SRI
|
-0.143x |
|
MMC Sanayi ve Ticari Yatirimlar AS
IS:MMCAS
|
0.001x |
Annual Cash Flow Conversion Efficiency for IBKS No3 SPAC (2016–2025)
The table below shows the annual cash flow conversion efficiency of IBKS No3 SPAC from 2016 to 2025. Review 225430 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩28.27 Billion ≈ $19.16 Million |
₩-1.75 Billion ≈ $-1.19 Million |
-0.062x | +0.76% |
| 2024-12-31 | ₩32.62 Billion ≈ $22.10 Million |
₩-2.04 Billion ≈ $-1.38 Million |
-0.062x | -253.12% |
| 2023-12-31 | ₩35.48 Billion ≈ $24.04 Million |
₩1.45 Billion ≈ $980.06K |
0.041x | +1686.79% |
| 2022-12-31 | ₩36.33 Billion ≈ $24.62 Million |
₩-93.32 Million ≈ $-63.24K |
-0.003x | -104.52% |
| 2021-12-31 | ₩39.91 Billion ≈ $27.04 Million |
₩2.27 Billion ≈ $1.54 Million |
0.057x | +154.79% |
| 2020-12-31 | ₩40.77 Billion ≈ $27.63 Million |
₩909.18 Million ≈ $616.14K |
0.022x | +176.93% |
| 2019-12-31 | ₩24.19 Billion ≈ $16.40 Million |
₩-701.24 Million ≈ $-475.22K |
-0.029x | -156.77% |
| 2018-12-31 | ₩23.83 Billion ≈ $16.15 Million |
₩1.22 Billion ≈ $824.56K |
0.051x | +1058.34% |
| 2017-12-31 | ₩8.48 Billion ≈ $5.74 Million |
₩-45.15 Million ≈ $-30.60K |
-0.005x | +35.53% |
| 2016-12-31 | ₩8.46 Billion ≈ $5.73 Million |
₩-69.90 Million ≈ $-47.37K |
-0.008x | -- |
About IBKS No3 SPAC
KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more